AIMC Topic: Glucagon-Like Peptide 1

Clear Filters Showing 1 to 2 of 2 articles

Computational approaches for clinical, genomic and proteomic markers of response to glucagon-like peptide-1 therapy in type-2 diabetes mellitus: An exploratory analysis with machine learning algorithms.

Diabetes & metabolic syndrome Jul 23, 2024
INTRODUCTION: In 2021, the International Diabetes Federation reported that 537 million people worldwide are living with diabetes. While glucagon-like peptide-1 agonists provide significant benefits in diabetes management, approximately 40% of patient...
Humans Machine Learning Algorithms Biomarkers Prognosis Female Male Middle Aged Diabetes Mellitus, Type 2 Genomics Computational Biology Proteomics Hypoglycemic Agents Follow-Up Studies Glycated Hemoglobin Glucagon-Like Peptide 1
View on PubMed DOI

Resolution of type 2 diabetes after sleeve gastrectomy: a 2-step hypothesis.

Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery Dec 14, 2017
BACKGROUND: Weight loss (WL) and altered gut hormonal levels are involved in glucose homeostasis after laparoscopic sleeve gastrectomy (LSG).
Humans Prospective Studies Female Young Adult Adult Male Middle Aged Weight Loss Blood Glucose Insulin Diabetes Mellitus, Type 2 Insulin Resistance Laparoscopy Glycated Hemoglobin Gastrectomy Bariatric Surgery Obesity, Morbid Insulin Secretion Ghrelin Glucagon-Like Peptide 1
View on PubMed DOI
Popular Topics
Recent Journals